Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGaur, Atul-
dc.contributor.otherArabi, Y.-
dc.contributor.otherAl-Hameed, F.-
dc.contributor.otherBurns, K.E.A-
dc.contributor.otherMehta, S.-
dc.contributor.otherAlsolamy, S.-
dc.contributor.otherAlmaani, M.-
dc.contributor.otherMandourah, Y.-
dc.contributor.otherAlmekhlafi, G.A.-
dc.contributor.otherAl Bshabshe, A.-
dc.contributor.otherFinfer, S.-
dc.contributor.otherAlshahrani, M.-
dc.contributor.otherKhalid, I.-
dc.contributor.otherMehta, Y.-
dc.contributor.otherHawa, H.-
dc.contributor.otherBuscher, H.-
dc.contributor.otherArshad, Z.-
dc.contributor.otherLababidi, H.-
dc.contributor.otherAl Aithan, A.-
dc.contributor.otherJose, J.-
dc.contributor.otherAbdukahil, S.A.I.-
dc.contributor.otherAfesh, L.Y.-
dc.contributor.otherDbsawy, M.-
dc.contributor.otherAl-Dawood, A.-
dc.description.abstractBACKGROUND: The Pneumatic CompREssion for Preventing VENous Thromboembolism (PREVENT) trial evaluates the effect of adjunctive intermittent pneumatic compression (IPC) with pharmacologic thromboprophylaxis compared to pharmacologic thromboprophylaxis alone on venous thromboembolism (VTE) in critically ill adults. METHODS/DESIGN: In this multicenter randomized trial, critically ill patients receiving pharmacologic thromboprophylaxis will be randomized to an IPC or a no IPC (control) group. The primary outcome is "incident" proximal lower-extremity deep vein thrombosis (DVT) within 28 days after randomization. Radiologists interpreting the lower-extremity ultrasonography will be blinded to intervention allocation, whereas the patients and treating team will be unblinded. The trial has 80% power to detect a 3% absolute risk reduction in the rate of proximal DVT from 7% to 4%. DISCUSSION: Consistent with international guidelines, we have developed a detailed plan to guide the analysis of the PREVENT trial. This plan specifies the statistical methods for the evaluation of primary and secondary outcomes, and defines covariates for adjusted analyses a priori. Application of this statistical analysis plan to the PREVENT trial will facilitate unbiased analyses of clinical data. TRIAL REGISTRATION: , ID: NCT02040103 . Registered on 3 November 2013; Current controlled trials, ID: ISRCTN44653506 . Registered on 30 October 2013.en
dc.description.sponsorshipIntensive Careen
dc.subjectDrug Therapyen
dc.titleStatistical analysis plan for the Pneumatic CompREssion for PreVENting Venous Thromboembolism (PREVENT) trial: a study protocol for a randomized controlled trialen
dc.typeJournal Articleen
dc.description.affiliatesCentral Coast Local Health Districten
dc.description.affiliatesGosford Hospitalen
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
Appears in Collections:Neurology
Show simple item record

Page view(s)

checked on Mar 23, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.